CANINE CORONAVIRUS VACCINE

Publication Date

​

Patent Number

WO8500014A1

Abstract

An efficacious parenterally administered attenuated or inactivated canine coronavirus vaccine which provides systemic, humoral protection and also protection of the intestinal tract in dogs from infection by virulent canine coronavirus is produced. A method for propagation of the canine coronavirus and its attenuation or inactivation and a method of evaluating the effectiveness of a canine coronavirus vaccine in canines is also disclosed. Adjuvants for use with veterinary vaccines are also disclosed.